Vaxcyte, Inc.
US ˙ NasdaqGS ˙ US92243G1085

Introduction

This page provides a comprehensive analysis of the known insider trading history of Jeff Fairman. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Jeff Fairman has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:PCVX / Vaxcyte, Inc. VP, Research 286,227
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Jeff Fairman. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases PCVX / Vaxcyte, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in PCVX / Vaxcyte, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PCVX / Vaxcyte, Inc. Insider Trades
Insider Sales PCVX / Vaxcyte, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in PCVX / Vaxcyte, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PCVX / Vaxcyte, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Jeff Fairman as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2022-10-28 2022-10-26 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -10,000 286,227 -3.38 40.00 -400,000 11,449,080
2022-10-13 2022-10-11 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -5,000 296,227 -1.66 25.50 -127,500 7,553,788
2022-09-07 2022-09-06 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -336 301,227 -0.11 27.14 -9,118 8,174,759
2022-09-07 2022-09-06 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -4,664 301,563 -1.52 26.54 -123,774 8,002,909
2022-09-07 2022-09-02 4 PCVX Vaxcyte, Inc.
Common Stock
F - Taxes -519 17,143 -2.94 26.38 -13,691 452,232
2022-08-05 2022-08-05 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -5,000 306,227 -1.61 25.70 -128,508 7,870,493
2022-08-05 2022-08-04 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -10,000 311,227 -3.11 25.50 -255,000 7,936,288
2022-05-24 2022-05-20 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -4,112 321,227 -1.26 25.50 -104,856 8,191,288
2022-05-09 2022-05-05 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -888 325,339 -0.27 25.80 -22,914 8,395,210
2022-04-07 2022-04-05 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -5,000 326,227 -1.51 25.59 -127,950 8,348,149
2022-03-15 2022-03-11 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -10,000 331,227 -2.93 25.50 -255,000 8,446,288
2022-03-04 2022-03-02 4 PCVX Vaxcyte, Inc.
Stock Option (right to buy)
A - Award 33,000 33,000
2022-03-04 2022-03-02 4 PCVX Vaxcyte, Inc.
Common Stock
A - Award 6,000 16,629 56.45
2022-02-08 2021-12-20 4 PCVX Vaxcyte, Inc.
Stock Option (right to buy)
M - Exercise -4,469 53,626 -7.69
2022-02-08 2021-12-20 4 PCVX Vaxcyte, Inc.
Common Stock
M - Exercise 4,469 10,629 72.55 1.79 8,000 19,026
2021-12-28 2021-12-27 4 PCVX Vaxcyte, Inc.
Stock Option (right to buy)
M - Exercise -4,750 53,345 -8.18
2021-12-28 2021-12-27 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -175 6,160 -2.76 24.08 -4,214 148,333
2021-12-28 2021-12-27 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -4,575 6,335 -41.93 23.58 -107,878 149,379
2021-12-28 2021-12-27 4 PCVX Vaxcyte, Inc.
Common Stock
M - Exercise 4,750 10,910 77.11 1.79 8,502 19,529
2021-12-20 2021-12-16 4 PCVX Vaxcyte, Inc.
Stock Option (right to buy)
M - Exercise -4,619 58,095 -7.37
2021-12-20 2021-12-16 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -4,619 6,160 -42.85 22.50 -103,928 138,600
2021-12-20 2021-12-16 4 PCVX Vaxcyte, Inc.
Common Stock
M - Exercise 4,619 10,779 74.98 1.79 8,268 19,294
2021-12-13 2021-12-09 4 PCVX Vaxcyte, Inc.
Stock Option (right to buy)
M - Exercise -131 62,714 -0.21
2021-12-13 2021-12-09 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -131 6,160 -2.08 22.50 -2,948 138,600
2021-12-13 2021-12-09 4 PCVX Vaxcyte, Inc.
Common Stock
M - Exercise 131 6,291 2.13 1.79 234 11,261
2021-10-28 2021-10-26 4 PCVX Vaxcyte, Inc.
Stock Option (right to buy)
M - Exercise -4,750 62,845 -7.03
2021-10-28 2021-10-26 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -4,750 5,144 -48.01 22.69 -107,778 116,717
2021-10-28 2021-10-26 4 PCVX Vaxcyte, Inc.
Common Stock
M - Exercise 4,750 9,894 92.34 1.79 8,502 17,710
2021-09-29 2021-09-27 4 PCVX Vaxcyte, Inc.
Stock Option (right to buy)
M - Exercise -4,750 67,595 -6.57
2021-09-29 2021-09-27 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -139 5,144 -2.63 26.47 -3,679 136,162
2021-09-29 2021-09-27 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -4,611 5,283 -46.60 26.16 -120,624 138,203
2021-09-29 2021-09-27 4 PCVX Vaxcyte, Inc.
Common Stock
M - Exercise 4,750 9,894 92.34 1.79 8,502 17,710
2021-08-30 2021-08-26 4 PCVX Vaxcyte, Inc.
Stock Option (right to buy)
M - Exercise -4,750 72,345 -6.16
2021-08-30 2021-08-26 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -3,218 5,144 -38.48 25.70 -82,703 132,201
2021-08-30 2021-08-26 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -1,532 8,362 -15.48 24.70 -37,840 206,541
2021-08-30 2021-08-26 4 PCVX Vaxcyte, Inc.
Common Stock
M - Exercise 4,750 9,894 92.34 1.79 8,502 17,710
2021-07-28 2021-07-26 4 PCVX Vaxcyte, Inc.
Stock Option (right to buy)
M - Exercise -4,750 77,095 -5.80
2021-07-28 2021-07-26 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -4,750 5,144 -48.01 22.70 -107,825 116,769
2021-07-28 2021-07-26 4 PCVX Vaxcyte, Inc.
Common Stock
M - Exercise 4,750 9,894 92.34 1.79 8,502 17,710
2021-06-30 2021-06-28 4 PCVX Vaxcyte, Inc.
Stock Option (right to buy)
M - Exercise -4,750 81,845 -5.49
2021-06-30 2021-06-28 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -136 5,144 -2.58 24.80 -3,373 127,571
2021-06-30 2021-06-28 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -4,614 5,280 -46.63 24.36 -112,397 128,621
2021-06-30 2021-06-28 4 PCVX Vaxcyte, Inc.
Common Stock
M - Exercise 4,750 9,894 92.34 1.79 8,502 17,710
2021-06-09 2021-06-07 4 PCVX Vaxcyte, Inc.
Stock Option (right to buy)
M - Exercise -2,241 86,595 -2.52
2021-06-09 2021-06-07 4 PCVX Vaxcyte, Inc.
Stock Option (right to buy)
M - Exercise -7,259 0 -100.00
2021-06-09 2021-06-07 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -9,500 5,144 -64.87 22.50 -213,750 115,740
2021-06-09 2021-06-07 4 PCVX Vaxcyte, Inc.
Common Stock
M - Exercise 2,241 14,644 18.07 1.79 4,011 26,213
2021-06-09 2021-06-07 4 PCVX Vaxcyte, Inc.
Common Stock
M - Exercise 7,259 12,403 141.12 0.04 290 496
2021-04-23 2021-04-22 4 PCVX Vaxcyte, Inc.
Stock Option (right to buy)
M - Exercise -2,793 88,836 -3.05
2021-04-23 2021-04-22 4 PCVX Vaxcyte, Inc.
Common Stock
M - Exercise 2,793 4,201 198.37 1.79 4,999 7,520
2021-04-06 2021-04-01 4 PCVX Vaxcyte, Inc.
Stock Option (right to buy)
A - Award 40,000 40,000
2021-03-29 2021-03-26 4 PCVX Vaxcyte, Inc.
Stock Option (right to buy)
M - Exercise -4,750 7,259 -39.55
2021-03-29 2021-03-26 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -1,361 1,408 -49.15 24.48 -33,317 34,468
2021-03-29 2021-03-26 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -3,389 2,769 -55.03 23.64 -80,116 65,459
2021-03-29 2021-03-26 4 PCVX Vaxcyte, Inc.
Common Stock
M - Exercise 4,750 6,158 337.36 0.04 190 246
2021-03-02 2021-02-26 4 PCVX Vaxcyte, Inc.
Stock Option (right to buy)
M - Exercise -4,750 12,009 -28.34
2021-03-02 2021-02-26 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -68 1,408 -4.61 25.33 -1,722 35,665
2021-03-02 2021-02-26 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -1,372 1,476 -48.17 24.34 -33,394 35,926
2021-03-02 2021-02-26 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -3,310 2,848 -53.75 23.73 -78,546 67,583
2021-03-02 2021-02-26 4 PCVX Vaxcyte, Inc.
Common Stock
M - Exercise 4,750 6,158 337.36 0.04 190 246
2021-01-28 2021-01-26 4 PCVX Vaxcyte, Inc.
Stock Option (right to buy)
M - Exercise -4,750 16,759 -22.08
2021-01-28 2021-01-26 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -425 1,408 -23.19 25.94 -11,024 36,524
2021-01-28 2021-01-26 4 PCVX Vaxcyte, Inc.
Common Stock
S - Sale X -4,325 1,833 -70.23 25.20 -108,990 46,192
2021-01-28 2021-01-26 4 PCVX Vaxcyte, Inc.
Common Stock
M - Exercise 4,750 6,158 337.36 0.04 190 246
2020-12-30 2020-12-29 4 PCVX Vaxcyte, Inc.
Stock Option (right to buy)
M - Exercise -740 91,629 -0.80
2020-12-30 2020-12-29 4 PCVX Vaxcyte, Inc.
Common Stock
M - Exercise 740 1,408 110.78 1.79 1,325 2,520
2020-06-11 3 PCVX Vaxcyte, Inc.
Common Stock
782,454
2020-06-11 3 PCVX Vaxcyte, Inc.
Common Stock
782,454
2020-06-11 3 PCVX Vaxcyte, Inc.
Common Stock
782,454
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)